Leibler, C.; Moktefi, A.; Matignon, M.; Debiais-Delpech, C.; Oniszczuk, J.; Sahali, D.; Cohen, J.L.; Grimbert, P.; Audard, V.
Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring. J. Clin. Med. 2018, 7, 430.
https://doi.org/10.3390/jcm7110430
AMA Style
Leibler C, Moktefi A, Matignon M, Debiais-Delpech C, Oniszczuk J, Sahali D, Cohen JL, Grimbert P, Audard V.
Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring. Journal of Clinical Medicine. 2018; 7(11):430.
https://doi.org/10.3390/jcm7110430
Chicago/Turabian Style
Leibler, Claire, Anissa Moktefi, Marie Matignon, Céline Debiais-Delpech, Julie Oniszczuk, Dil Sahali, José L. Cohen, Philippe Grimbert, and Vincent Audard.
2018. "Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring" Journal of Clinical Medicine 7, no. 11: 430.
https://doi.org/10.3390/jcm7110430
APA Style
Leibler, C., Moktefi, A., Matignon, M., Debiais-Delpech, C., Oniszczuk, J., Sahali, D., Cohen, J. L., Grimbert, P., & Audard, V.
(2018). Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring. Journal of Clinical Medicine, 7(11), 430.
https://doi.org/10.3390/jcm7110430